CPT® Code 86769

The CPT® Code 86769 refers to the laboratory test for the detection of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for coronavirus disease (COVID-19). This test is crucial for diagnosing both current and past infections of COVID-19. The common language description highlights the use of enzyme-linked immunosorbent assays (ELISA), which are sophisticated, multi-step laboratory methods designed to identify the presence of immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies in a patient's serum or plasma. IgG antibodies are typically produced in response to an infection and remain in the body for an extended period, indicating a past infection or a long-term immune response. Conversely, IgM antibodies are the first type of antibody produced during an initial immune response, making them valuable for identifying recent infections. The testing process involves diluting the patient's sample, applying it to microplate wells coated with SARS-CoV-2 recombinant antigens, and following a series of incubation and washing steps. The presence of antibodies is determined through a colorimetric measurement, where a chromogenic substrate reacts with an enzyme-labeled antibody, resulting in a color change that correlates with the concentration of antibodies in the sample. This detailed methodology underscores the importance of the test in both clinical diagnostics and public health monitoring during the COVID-19 pandemic.